Operating Income Summary of Qiagen N.V.

Qiagen N.V.'s latest annual operating income in 2023 was 445.24 Million USD , down -16.22% from previous year.
Qiagen N.V.'s latest quarterly operating income in 2024 Q2 was 122.8 Million USD , down -332.52% from previous quarter.
Qiagen N.V. reported an annual operating income of 531.46 Million USD in 2022, down -15.65% from previous year.
Qiagen N.V. reported an annual operating income of 630.08 Million USD in 2021, up 13.55% from previous year.
Qiagen N.V. reported a quarterly operating income of 122.8 Million USD for 2024 Q2, down -332.52% from previous quarter.
Qiagen N.V. reported a quarterly operating income of 129.05 Million USD for 2023 Q1, up 23.41% from previous quarter.

Annual Operating Income Chart of Qiagen N.V. (2023 - 1995)

Historical Annual Operating Income of Qiagen N.V. (2023 - 1995)

Year	Operating Income	Operating Income Growth
2023	445.24 Million USD	-16.22%
2022	531.46 Million USD	-15.65%
2021	630.08 Million USD	13.55%
2020	554.9 Million USD	65.04%
2019	336.21 Million USD	26.12%
2018	266.58 Million USD	73.76%
2017	153.41 Million USD	55.24%
2016	98.82 Million USD	-43.75%
2015	175.69 Million USD	9.25%
2014	160.81 Million USD	153.94%
2013	63.33 Million USD	-62.71%
2012	169.81 Million USD	70.52%
2011	99.58 Million USD	-47.18%
2010	188.53 Million USD	4.62%
2009	180.2 Million USD	23.71%
2008	145.66 Million USD	75.22%
2007	83.13 Million USD	-17.36%
2006	100.6 Million USD	6.08%
2005	94.83 Million USD	12.71%
2004	84.14 Million USD	22.14%
2003	68.88 Million USD	59.52%
2002	43.18 Million USD	-19.24%
2001	53.47 Million USD	53.35%
2000	34.87 Million USD	31.76%
1999	26.46 Million USD	81.28%
1998	14.6 Million USD	75.9%
1997	8.3 Million USD	38.33%
1996	6 Million USD	27.66%
1995	4.7 Million USD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	98.24 Million USD	-26.95%
2024 Q2	122.8 Million USD	-332.52%
2023 Q1	129.05 Million USD	23.41%
2023 Q3	97.18 Million USD	-7.83%
2023 Q4	134.49 Million USD	38.39%
2023 FY	445.24 Million USD	-16.22%
2023 Q2	105.43 Million USD	-18.3%
2022 Q1	207.07 Million USD	19.6%
2022 Q4	104.57 Million USD	-24.34%
2022 FY	531.46 Million USD	-15.65%
2022 Q2	122.15 Million USD	-41.01%
2022 Q3	138.22 Million USD	13.15%
2021 Q2	-161.27 Million USD	-198.46%
2021 Q4	173.14 Million USD	31.29%
2021 FY	630.08 Million USD	13.55%
2021 Q1	163.79 Million USD	5.06%
2021 Q3	131.87 Million USD	181.77%
2020 Q2	118.69 Million USD	76.33%
2020 FY	554.9 Million USD	65.04%
2020 Q1	67.31 Million USD	-15.85%
2020 Q3	44.5 Million USD	-62.5%
2020 Q4	155.91 Million USD	250.31%
2019 FY	336.21 Million USD	26.12%
2019 Q1	41.15 Million USD	-53.38%
2019 Q2	60.17 Million USD	46.23%
2019 Q3	-207.45 Million USD	-444.74%
2019 Q4	79.98 Million USD	138.56%
2018 Q4	88.27 Million USD	14.59%
2018 Q3	77.03 Million USD	44.44%
2018 Q2	53.33 Million USD	11.24%
2018 Q1	47.94 Million USD	10.54%
2018 FY	266.58 Million USD	73.76%
2017 Q1	23.75 Million USD	466.44%
2017 Q4	43.37 Million USD	-32.16%
2017 FY	153.41 Million USD	55.24%
2017 Q3	63.93 Million USD	185.85%
2017 Q2	22.36 Million USD	-5.84%
2016 Q4	4.19 Million USD	-91.07%
2016 Q1	15.4 Million USD	-71.69%
2016 Q2	29.48 Million USD	91.42%
2016 Q3	46.97 Million USD	59.33%
2016 FY	98.82 Million USD	-43.75%
2015 Q1	35.13 Million USD	70.8%
2015 FY	175.69 Million USD	9.25%
2015 Q3	46.17 Million USD	15.47%
2015 Q2	39.98 Million USD	13.82%
2015 Q4	54.4 Million USD	17.83%
2014 Q1	42.3 Million USD	24.39%
2014 Q4	20.56 Million USD	-59.07%
2014 FY	160.81 Million USD	153.94%
2014 Q2	47.69 Million USD	12.74%
2014 Q3	50.25 Million USD	5.37%
2013 Q1	29.07 Million USD	-40.58%
2013 FY	63.33 Million USD	-62.71%
2013 Q4	34 Million USD	-1.17%
2013 Q3	34.41 Million USD	200.73%
2013 Q2	-34.16 Million USD	-217.51%
2012 FY	169.81 Million USD	70.52%
2012 Q3	38.97 Million USD	-14.2%
2012 Q2	45.42 Million USD	24.52%
2012 Q1	36.48 Million USD	286.04%
2012 Q4	48.92 Million USD	25.52%
2011 Q4	-19.61 Million USD	-157.18%
2011 Q1	38.44 Million USD	-24.28%
2011 Q2	46.45 Million USD	20.83%
2011 FY	99.58 Million USD	-47.18%
2011 Q3	34.29 Million USD	-26.17%
2010 Q1	44.68 Million USD	4.05%
2010 Q2	42.85 Million USD	-4.1%
2010 Q3	50.23 Million USD	17.23%
2010 FY	188.53 Million USD	4.62%
2010 Q4	50.77 Million USD	1.07%
2009 Q2	46.88 Million USD	26.61%
2009 Q3	53.35 Million USD	13.8%
2009 FY	180.2 Million USD	23.71%
2009 Q4	42.94 Million USD	-19.52%
2009 Q1	37.02 Million USD	-8.43%
2008 Q4	40.43 Million USD	5.91%
2008 FY	145.66 Million USD	75.22%
2008 Q1	33.03 Million USD	32.09%
2008 Q3	38.17 Million USD	12.25%
2008 Q2	34.01 Million USD	2.95%
2007 FY	83.13 Million USD	-17.36%
2007 Q4	25.01 Million USD	1561.78%
2007 Q2	31.03 Million USD	7.78%
2007 Q1	28.79 Million USD	7.06%
2007 Q3	-1.71 Million USD	-105.51%
2006 Q4	26.89 Million USD	0.58%
2006 Q2	21.71 Million USD	-13.98%
2006 Q1	25.24 Million USD	-2.8%
2006 Q3	26.74 Million USD	23.15%
2006 FY	100.6 Million USD	6.08%
2005 Q4	25.97 Million USD	0.37%
2005 FY	94.83 Million USD	12.71%
2005 Q1	21.39 Million USD	-3.87%
2005 Q2	21.59 Million USD	0.96%
2005 Q3	25.87 Million USD	19.8%
2004 Q4	22.25 Million USD	6.46%
2004 Q3	20.9 Million USD	-8.68%
2004 Q2	22.89 Million USD	26.53%
2004 Q1	18.09 Million USD	11.89%
2004 FY	84.14 Million USD	22.14%
2003 FY	68.88 Million USD	59.52%
2003 Q2	17.31 Million USD	7.62%
2003 Q1	16.09 Million USD	210.9%
2003 Q4	16.16 Million USD	-16.27%
2003 Q3	19.31 Million USD	11.5%
2002 FY	43.18 Million USD	-19.24%
2002 Q1	15.71 Million USD	-8.26%
2002 Q2	9.35 Million USD	-40.48%
2002 Q3	12.94 Million USD	38.42%
2002 Q4	5.17 Million USD	-60.02%
2001 Q3	10.08 Million USD	-31.67%
2001 FY	53.47 Million USD	53.35%
2001 Q4	17.12 Million USD	69.89%
2001 Q1	11.51 Million USD	103.12%
2001 Q2	14.75 Million USD	28.12%
2000 Q3	10.58 Million USD	-0.08%
2000 FY	34.87 Million USD	31.76%
2000 Q4	5.66 Million USD	-46.42%
2000 Q2	10.59 Million USD	43.05%
2000 Q1	7.4 Million USD	-0.78%
1999 FY	26.46 Million USD	81.28%
1999 Q1	5.7 Million USD	67.65%
1999 Q2	6.2 Million USD	8.77%
1999 Q3	7.2 Million USD	16.26%
1999 Q4	7.46 Million USD	3.51%
1998 Q3	4.5 Million USD	32.35%
1998 Q2	3.4 Million USD	-8.11%
1998 Q1	3.7 Million USD	85.0%
1998 FY	14.6 Million USD	75.9%
1998 Q4	3.4 Million USD	-24.44%
1997 Q2	2 Million USD	0.0%
1997 Q1	2 Million USD	106.02%
1997 Q4	2 Million USD	-9.09%
1997 Q3	2.2 Million USD	10.0%
1997 FY	8.3 Million USD	38.33%
1996 Q4	-33.2 Million USD	-333.8%
1996 Q1	1.9 Million USD	0.0%
1996 FY	6 Million USD	27.66%
1996 Q3	14.2 Million USD	12.7%
1996 Q2	12.6 Million USD	563.16%
1995 FY	4.7 Million USD	0.0%

Peer Operating Income Comparison of Qiagen N.V.

Name	Operating Income	Operating Income Difference
Agilent Technologies, Inc.	1.35 Billion USD	67.019%
Charles River Laboratories International, Inc.	617.26 Million USD	27.867%
Quest Diagnostics Incorporated	1.26 Billion USD	64.719%
Danaher Corporation	5.2 Billion USD	91.441%
Enzo Biochem, Inc.	-9.81 Million USD	4635.469%
IQVIA Holdings Inc.	1.97 Billion USD	77.479%
Laboratory Corporation of America Holdings	725.6 Million USD	38.637%
Mettler-Toledo International Inc.	1.15 Billion USD	61.347%
Revvity, Inc.	300.56 Million USD	-48.138%
Thermo Fisher Scientific Inc.	6.85 Billion USD	93.509%
Waters Corporation	817.67 Million USD	45.547%

Global Stocks Search

Qiagen N.V. (QGEN)

Operating Income Summary of Qiagen N.V.

Annual Operating Income Chart of Qiagen N.V. (2023 - 1995)

Historical Annual Operating Income of Qiagen N.V. (2023 - 1995)

Peer Operating Income Comparison of Qiagen N.V.